Tasigna 150 mg hard capsules clinical trials

Multicenter prospective trial after first or second unsuccessful treatment discontinuation in chronic myeloid leukemia estimating the efficacy of nilotinib in inducing the persistence of molecular remission after stopping TKI 2nd or 3rd time

This study looks at how well a medicine called nilotinib works for people with a type of blood cancer called Chronic Myeloid Leukaemia (CML). It's for patients who tried to stop their CML treatment before, but it didn't work. We want to see if nilotinib helps them stay cancer-free after trying to stop treatment again.